From: Predictors of the chest CT score in COVID-19 patients: a cross-sectional study
Variables | All patients N = 478 |
---|---|
Demographics | |
Age (years) | 53.92(15.4) |
 < 39 | 90 (18.8%) |
 39–49 | 102 (21.3%) |
 50–59 | 104 (21.7%) |
 60–69 | 98 (20.5%) |
 ≥ 70 | 84 (17.5%) |
Gender (male) | 267 (55.8%) |
Symptoms on the first visit | |
Myalgia | 289 (60.4%) |
Generalized weakness | 217 (45.3%) |
Fever | 284 (59.4%) |
Chills | 237 (49.5%) |
Headache | 134 (28%) |
Chest pain | 126 (26.3%) |
Dyspnea | 277 (57.9%) |
Sore throat | 80 (16.7%) |
Cough | 334 (69.8%) |
Sputum | 15 (3.1%) |
Loss of appetite | 194 (40.5%) |
Loss of taste | 48 (10%) |
Anosmia | 60 (12.5%) |
Vital signs on first visit | |
Temperature (°C) |  |
 ≤ 37.2 | 212 (44.3%) |
 ≥ 37.3 | 266 (55.7%) |
O2 saturation % | Â |
 ≥ 93 | 276 (57.7%) |
 < 93 | 202 (42.3%) |
Respiratory rate (breaths/minute) | |
 < 25 | 389 (81.3%) |
 ≥ 25 | 89 (18.7%) |
Initial laboratory findings | |
White blood cell (WBC) (cell/ mm3) | Â |
 < 4000 | 51 (10.6%) |
 4000–9999 | 364 (76.3%) |
 ≥ 10,000 | 63 (13.1%) |
Lymphocyte count (cell/ mm3) | |
 ≤ 1000 | 103 (21.5%) |
 > 1000 | 375 (78.5%) |
Platelet (cell/mm3) | |
 < 150,000 | 82 (17.1%) |
 ≥ 150,000 | 396 (82.9%) |
C-reactive protein (CRP) (mg/L) | |
 ≤ 90 | 17 (3.5%) |
 ≥ 91 | 461 (96.5%) |
Erythrocyte sedimentation rate (ESR) (mm/h) | |
 ≤ 60 | 13 (2.7%) |
 ≥ 61 | 465 (97.3%) |
Lactate dehydrogenase (LDH) (units/L) | |
 < 480 | 65 (13.5%) |
 ≥ 480 | 413 (86.5%) |
Underlying disease | |
 DM | 132 (27.6%) |
 HTN | 136 (28.4%) |